According to a study published by the Institute of Psychiatry, CBD offered psychiatric potential, including use as an antidepressant-like and anxiolytic-like compound. During the study, animals who had been given CBD experienced lower levels of anxiety and depression in a series of tests, such as swimming and puzzle mazes, than animals who had not been given CBD. Another study aimed to investigate the use of CBD for treating a social anxiety disorder. The study, published by the Department of Neurosciences and Behavior, Division of Psychiatry, found that CBD was associated with decreased subjective anxiety. Results suggested that CBD reduced anxiety in social anxiety disorder patients because it is related to CBD’s effects on activity in specific mood-altering brain areas.
(Source: de Mello Schiere, Alexander et al. “Antidepressant-like and Anxiolytic-like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa.” CNS & Neurological Disorders – Drug Targets, 2014, 13, 953-960.